A 28-year-old male was admitted to hospital with a brief history of altered mental state, vomiting and lethargy. Having been out with friends four days earlier, he had woken up the next day with symptoms of lethargy and general malaise, initially attributed to a hangover. However, his symptoms failed to resolve and after several days of deterioration, he was brought to hospital by his partner.
On examination, he was found to be mildly confused with an initial GCS of 14-15, but with no other focal neurological signs. General physical examination revealed no other abnormalities. At this point, his partner volunteered that the patient had recently taken up bodybuilding and may have been using anabolic steroids and testosterone supplements.
He was admitted for observation and investigations. A CT scan of the head was reported as normal. With the exception of a raised alanine transaminase (ALT) level and raised bilirubin, all other investigations were normal.
Over the next two days, his sensorium deteriorated with his GCS dropping to 3-5/15. A further CT scan showed mild cerebral oedema. He was admitted to ICU, intubated and mechanically ventilated. Blood tests revealed a serum ammonia which was elevated, at 420 µmol/L (normal range 0-50 µmol/L). After discussion with a liver unit, it was considered that this could be a presentation of late-onset urea cycle disorder. Appropriate tests were sent, including plasma and urinary amino acids, and levels for citrulline, arginosuccinic acid and glutamine. Urine was also sent for inorganic acid, orotic acid and carnitine levels.
The initial goal was to try to reduce the serum ammonia level. This involved a zero protein diet and continuous venovenous haemofiltration (CVVH) using a HF 12 Aquamax filter (overall unit length 305 mm, effective fibre length 241 mm, membrane area 1.2 m 2 , fibre internal diameter 200 microns) with a flow rate of 35 mL/kg/hr. However, despite an initial drop in the ammonia level, after 27 hours of CVVH the levels had risen again and over the next 36 hours he deteriorated further, culminating in an episode that was highly suggestive of brain stem death. A repeat CT scan showed severe cerebral oedema with evidence of brain stem herniation.
At this time, results of tests were not available to confirm a diagnosis of urea cycle disorder. Given that his serum ammonia was persistently high, it was felt that brain stem testing could not be carried out. The liver unit advised us that we should aim for an ammonia level of less than 100 µmol/L before testing. After a literature search, the filtration strategy was changed from CVVH to CVVHDF (haemodiafiltration). This change resulted, in combination with a transfer to the CT scanner, in an eight-hour gap in filtration. CVVHDF was then started (HF 12 Aquamax, 35 mL/kg/hr exchange) and after 20 hours, the ammonia level dropped from 515 µmol/L to 94 µmol/L. Brain stem death testing was carried out, and he subsequently was an organ donor, with the consent of his family. The liver was not used because of the risk of passing on the potential urea cycle disorder.
Detailed test results were not available for another four weeks and, because the liver biopsy had been sent in formalin, it was unsuitable for genetic testing.
At the subsequent coroner' s inquest, it became clear that the family did not understand the condition and its implications for siblings, so a referral for genetic testing and counselling was arranged. This ultimately showed that the mother was a carrier for OTCD.
Pathophysiology of urea cycle disorders
The most common urea cycle disorder is OTCD, affecting approximately 1:42,000 live births; 1 however, this may be an
Ornithine transcarbamylase deficiency: diagnostic and management challenges in the ICU 1A01

P Watt, S lordache, P Russell
A young male patient presented with altered sensorium and rapid clinical deterioration following a short period of nonspecific illness and was subsequently diagnosed with ornithine transcarbamylase deficiency (OTCD). We discuss the pathophysiology of OTCD, the difficulties surrounding diagnosis and treatment, and highlight some of the controversies and general management issues of the disease.
Keywords: ornithine transcarbamylase deficiency; urea cycle disorder; organ donation; brain stem death testing; hyperammonaemia; continuous venovenous haemodiafiltration
underestimate as late onset presentations may go undetected. The overall incidence of urea cycle disorders is around 1:30,000 live births, although no population studies have ever been carried out. In April 2000 at the Urea Cycle Consensus Conference, it was suggested to be as high as 1:10,000 and may be the cause of death in up to 20% of babies with sudden infant death syndrome. 2 It is an X-linked condition, the consequence of this being that males are much more severely affected by the mutation, with only 15% of females ever showing symptoms. 4 The disease itself most often presents in the first few days following birth, in common with other urea cycle disorders. If unrecognised and untreated, affected males with severe OTCD generally die in the first week of life. However, it is not uncommon for milder versions of the disease to present later in life, as is the case with this patient. 5 These patients normally present after they are subjected to an abnormal nitrogen load. Some examples that have been reported include viral illness or other generalised stress responses, surgical damage, postpartum, GI bleeding, high protein diet, total parenteral nutrition, high dose steroids, chemotherapy, rapid weight loss or an acute chemical or viral insult to the liver.
Ornithine transcarbamylase itself is one of five enzymes responsible for the conversion of nitrogen to urea, whereby it can be excreted in the urine. These are carbamoylphosphate synthetase I, argininosuccinate synthetase, argininosuccinate lyase (argininosuccinase), arginase and ornithine transcarbamylase, all catalysing a different step in the pathway. The sixth enzyme that makes up the remaining disorder is N-acetylglutamate synthetase. Although not a true urea cycle enzyme, it catalyses the production of N-acetylglutamate from acetyl-CoA and glutamate and it is N-acetylglutamate that is responsible for the activation of the first enzyme in the cycle, carbamoylphosphate synthetase I.
OTC is the second enzyme in the urea cycle. Its role is to condense carbamyl phosphate and ornithine, both substrates for OTC, into citrulline. In the absence of OTC, there is an excess of both substrates, most importantly carbamyl phosphate. This impairs the reaction catalysed by carbamoylphosphate synthetase I, the combination of ammonia and bicarbonate to form carbamyl phosphate, (see Figure 1 ).
Excess ornithine leaks into the plasma and leads to high serum levels, whereas the excess carbamyl phosphate leaks into the cytosol. Here, it becomes the sole substrate for carbamyl phosphate synthetase II and orotic acid is formed. This is excreted by the kidneys.
The failure of any of these six enzymes results in ammonia production, not urea. Blood can absorb 1,000 mg of urea, but only 150 µg of ammonia, so the body very quickly becomes overwhelmed in the case of a breakdown of this very efficient system. Diagnosis is initially suspected by demonstration of serum hyperammonaemia. However, more specific tests include urinary orotic acid to creatinine ratio, (normally <3.5) and a liver biopsy. The mitochondrial enzyme OTC is subject to rapid post-mortem degradation so the biopsy must be performed prior to or immediately after death. Molecular testing to demonstrate enzyme deficiency is only 80% accurate.
Ammonia is a highly toxic substance, as it freely reacts with water to form ammonium hydroxide, a potent alkali, in an exothermic reaction that causes damage due to liquid putrefaction, which may account for the extensive neurological injury seen in acute hyperammonaemia. The liver is almost exclusively responsible for the metabolism and clearance of ammonia via the urea cycle. Ammonia is generated in the small and large intestine by the breakdown of glutamine. Muscle and kidney are net producers of ammonia but both have the ability to detoxify it. In chronic liver failure, skeletal muscle may become the main source of ammonia detoxification via muscular glutamine synthase. The kidneys can also increase their ammonia clearance from 30% of total to 70% under conditions of acidosis and liver failure. It has been observed that concomitant renal impairment worsens the degree of cognitive impairment associated with liver cirrhosis, suggesting that renal clearance becomes important under such circumstances. 5 Hyperammonaemia is defined by a serum ammonia value of over 50 µmol/L, (normal range 0-50 µmol/L). Signs and symptoms include anorexia, irritability, dyspnoea, lethargy and vomiting. Unchecked, the clinical picture soon progresses to cerebral symptoms as damage to cells causes cerebral oedema: disorientation, somnolence, combativeness, obtundation, coma and finally death due to high intracranial pressure and brain herniation.
Discussion
Late-onset OTCD is well documented but is commonly missed or overlooked at first presentation. The triggers are complex and poorly understood. There is an excessively high mortality at first presentation in adult patients with late onset OTCD which may be because of late recognition of the condition and consequent delayed instigation of effective treatment. Measurement of plasma ammonia levels should be a routine screening test for patients presenting with unexplained altered mental state. As late onset OTC deficiency is difficult to diagnose quickly, early interaction with a metabolic or liver specialist is advisable.
The patient had recently started on a bodybuilding 
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programme and so the combination of social alcohol consumption coupled with a high intake of protein could have generated the 'perfect storm' for provoking an acute rise in serum ammonia. The liver biopsy showed non-specific changes, possibly in keeping with a drug reaction. Steroids can lead to the development of severe cholestatic disease, which could account for the raised ALT. 7 Plasma ammonia levels must be reduced quickly in order to reduce morbidity and mortality as neurological outcome appears dependent on peak ammonia levels and coma duration before the start of dialysis. 8, 9 In late-onset OTCD, neuroimaging findings resemble those of extensive ischaemic strokes. These lesions may resolve completely or may result in mild atrophy of the affected areas with early treatment. 10 Whether this can be fully extrapolated to an adult population is unclear.
In this case, a much higher clearance of ammonia was apparently achieved with CVVHDF compared to CVVH. CVVHDF provides the best ammonia clearance compared to other methods of CRRT 11, 12 (see Figure 2 ). However, interpreting serial serum ammonia levels is difficult and in this case, a secondary rise was observed which could have been due to various factors such as renal impairment, tissue hypoperfusion or dehydration. In this case polyuria preceded the surge in ammonia suggesting that acute dehydration could have been contributory. However, renal parameters remained apparently stable throughout, although a small transient rise in serum sodium was noted.
Brain stem death testing is difficult in the context of an abnormally high serum ammonia. The ammonia level was 515 µmol/L at its peak, and we were advised that a level below 100 µmol/L was needed before testing. This is complicated by the observation that patients with levels as high as 140 µmol/L may be asymptomatic in chronic hyperammonaemia. 13 Recognition and diagnosis of OTCD is needed to prevent adverse consequences for potential organ recipients. 14 There are at least three case reports of patients who acquired OTCD following liver transplant from donors with unrecognised OTCD. 14, 15 Diagnosis is also essential for relatives as it has potential implications for other family members. Management strategies for asymptomatic family members may include: carrying an emergency letter/bracelet indicating that they are at risk of hyperammonaemia, monitoring of blood ammonia levels during intercurrent illnesses, ongoing dietary restriction of protein and supplementation with an essential amino acid formula. 16 Genetic counselling should be offered to all affected.
Conclusion
Presentation with an unexplained altered mental state should raise suspicion of urea cycle disorders, prompting measurement of serum ammonia. CVVHDF may be the preferred mode of filtration when aiming to achieve rapid clearance of ammonia.
The ramifications for relatives are important and consideration should be given to the potential problems of organ donation, if that is likely to proceed, especially if a diagnosis has not been definitively made.
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